What to know about new diagnostic tools, targeted medications, and other recent advances in the treatment of metastatic NSCLC.

Lung cancer is the one of the most common types of cancer doctors diagnose each year in the U.S. The most common kind of lung cancer is non-small-cell lung cancer (NSCLC). It makes up around 84% ...

Lung cancer is the leading cause of cancer deaths among both men and women. Small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC) are the two main types of lung cancer. Most lung ...

Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the ...

Highlights from ASCO 2025 in early-stage NSCLC include updates on CheckMate 816 on neoadjuvant nivolumab, NeoADAURA on osimertinib, and data on low-dose CT screening, presented by Dr Jonathan Goldman.

Lung cancer is the second most frequent cancer worldwide, and it accounts for 18% of all cancer-related deaths. Most cases of ...

Treatment choices for non-small cell lung cancer, by stage. American Cancer Society. Lung cancer statistics. Kelly CM, Shahrokni A. Moving beyond Karnofsky and ECOG Performance Status ...

TNM system to stage lung cancer, although it is typically used more for non-small cell lung cancer than SCLC, which doctors more often categorize as extensive or limited-stage. The TNM stages ...

Lung cancer is classified into two major categories: non-small cell lung cancer (NSCLC), which accounts for 85% of lung cancer cases, and small-cell lung cancer (SCLC), which accounts for the ...